Invesco Ltd. Roivant Sciences Ltd. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Invesco Ltd. holds 6,355,455 shares of ROIV stock, worth $76.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,355,455

Previous 5,908,065 7.57%

Holding current value

$76.1 Million

Previous $62.4 Million 17.44%

% of portfolio

0.01%

Previous 0.01%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$10.17 - $12.5 $4.55 Million - $5.59 Million	447,390 Added 7.57%	6,355,455 $73.3 Million
Q2 2024 Aug 13, 2024	BUY	$10.36 - $11.74 $56 Million - $63.4 Million	5,404,496 Added 1073.24%	5,908,065 $62.4 Million
Q1 2024 May 14, 2024	SELL	$9.87 - $11.8 $4.19 Million - $5.01 Million	-424,479 Reduced 45.74%	503,569 $5.31 Million
Q4 2023 Feb 12, 2024	SELL	$8.38 - $11.58 $3.79 Million - $5.23 Million	-451,937 Reduced 32.75%	928,048 $10.4 Million
Q3 2023 Nov 13, 2023	BUY	$9.76 - $13.19 $464,058 - $627,144	47,547 Added 3.57%	1,379,985 $16.1 Million
Q2 2023 Aug 11, 2023	BUY	$7.09 - $10.08 $4.21 Million - $5.99 Million	594,416 Added 80.54%	1,332,438 $13.4 Million
Q1 2023 May 12, 2023	BUY	$6.92 - $9.98 $1.64 Million - $2.37 Million	237,234 Added 47.37%	738,022 $5.45 Million
Q4 2022 Feb 13, 2023	BUY	$3.36 - $7.99 $1.63 Million - $3.88 Million	485,917 Added 3267.55%	500,788 $4 Million
Q3 2022 Nov 14, 2022	SELL	$0.51 - $4.84 $162 - $1,539	-318 Reduced 2.09%	14,871 $48,000
Q2 2022 Aug 15, 2022	BUY	$2.81 - $4.84 $42,681 - $73,514	15,189 New	15,189 $62,000

Others Institutions Holding ROIV

# of Institutions

310

Shares Held

507M

Call Options Held

1.26M

Put Options Held

2.52M

View Full List

About Roivant Sciences Ltd.

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.43B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

More about ROIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account